Home > Subject >

Complications and comorbidities

A School-Based Intervention for Diabetes Risk Reduction

Charles A. Reasner, M.D.
Volume 29, Number 4, pages 30-31

Addressing Residual Cardiovascular Risk

Charles A. Reasner, M.D.
Volume 29, Number 2, pages 30-31

Advanced Lipid Testing

Michael Cobble, M.D., A.A.F.P., F.N.L.A., and Jill Sellers, B.S.Pharm., Pharm.D.
Volume 29, Number 3, pages 22-26

AIM-HIGH Misses Its Target

Charles A. Reasner, M.D.
Volume 30, Number 3, pages 29-30

Alternatives to the Sleep Lab

Liz Seegert, M.A.
Volume 30, Number 2, pages 15-20

Ambulatory Blood Pressure Monitoring

Jennifer Beach, Pharm.D., and Kam Capoccia, Pharm.D., B.C.P.S.
Volume 23, Number 4, pages 12-16

An Evidence-Based Approach for Treating Hypertension in Diabetes

Jan N. Basile, M.D.
Volume 22, Number 2, pages 7-10

Anemia

Janis Bridge, M.D., and Irl B. Hirsch, M.D.
Volume 20, Number 4, pages 32-34

Anthropometric Measures As Predictors of Cardiometabolic Risk in Clinical Practice

Katia Cristina Portero McLellan, Ph.D., Nutrition, and Lance A. Sloan, M.D., M.Sc., F.A.C.E. Texas Institute for Kidney and Endocrine Disorders, Lufkin, Texas
Volume 35, Number 4, pages 8-11

Asymptomatic Bacteriuria in Women With Diabetes

Judith Richards, B.A., M.P.H., Robyn Stewart, B.A., Gul Bahtiyar, M.D., Martin Kramer, M.D., and Mary Ann Banerji, M.D.
Volume 24, Number 4, pages 17-20

Beyond Glycemic Control

Nandish Thurkal, M.D., Edward Bergen, D.O., Shailesh Nandish, M.D., Mike Lujan, B.S., Rene Oliveros, M.D., F.A.C.C., and Robert Chilton, D.O., F.A.C.C.
Volume 29, Number 1, pages 13-16

Can We "Drive Out" Obesity by Removing the Drive to Eat?

Aruna Venkatesh, M.D.
Volume 26, Number 3, pages 22-28

Cardiac Autonomic Neuropathy

Raimund I. Herzog, M.D., Deborah Chyun, Ph.D., R.N., F.A.H.A., and Lawrence H. Young, M.D.
Volume 25, Number 1, pages 34-38

Cardiometabolic Risk, Metabolic Syndrome, and Diabetes: Dysmetabolism and Cardiovascular Risk

Devan Shan, Samir Desai, M.D.
Volume 34, Number 1, pages 11-16

Celiac Disease

Marsha Mackenzie, M.S., R.D./L.D.
Volume 33, Number 3, pages 10-12

Clinical Appearance and Treatment of Adhesive Capsulitis in Diabetes

John D. MacGillivray, M.D., and Mark C. Drakos, B.A.
Volume 20, Number 2, pages 16-29

Clinical Controversies in Diabetes

Daniel L. Lorber, M.D.
Volume 21, Number 3, pages 22-32

Commentary: Application of the AACE 2017 Lipid Guidelines to Diabetes

Kathleen Wyne, M.D., Ph.D.
Volume 36, Number 3, pages 7-9

Commentary: CV Risk in Diabetes: T1D is not T2DM

Kathleen Wyne, M.D., Ph.D.
Volume 35, Number 5, pages 23-30

Current Evaluation and Management of Insulinoma

Pratima Kumar, M.D., and Charles A. Reasner, M.D.
Volume 27, Number 4, pages 10-13

Cystic Fibrosis-Related Diabetes

Anita Ramsetty, M.D., and Tracey McLaughlin, M.D., M.S.
Volume 24, Number 2, pages 23-29

Dental Issues in Patients With Diabetes

Geralyn R. Spollett, M.S.N., A.N.P., C.D.E., and Charles A. Crape, D.M.D.
Volume 26, Number 2, pages 28-31

Depression in Patients with Diabetes

William H. Polonsky, Ph.D., C.D.E., and Christopher G. Parkin, M.S.
Volume 20, Number 4, pages 20-29

Dermatologic Conditions in Patients With Diabetes

Suraj Reddy, M.D., Jeffrey J. Meffert, M.D., Eric W. Kraus, M.D., and Larry E. Becker, M.D.
Volume 27, Number 2, pages 6-10

Diabetes and Depression

Brad Rzepniewski, L.C.S.W., A.C.T.
Volume 30, Number 3, pages 25-28

Diabetes and the Risk of Disability


Volume 33, Number 2, pages 20-21

Diabetes in the Bedroom

Janis Roszler, R.D., C.D.E., L.D.N.
Volume 28, Number 2, pages 26-31

Diabetic Autonomic Neuropathy (Part 1)

J. Joseph Prendergast, M.D.
Volume 20, Number 1, pages 7-14

Diabetic Autonomic Neuropathy (Part 2)

J. Joseph Prendergast, M.D.
Volume 20, Number 2, pages 30-36

Diabetic Foot Pathology

Paul Kesselman, D.P.M, F.A.C.F.A.S., F.A.P.W.C.A.
Volume 25, Number 2, pages 41-43

Diabetic Gastroparesis

Ira Daniel Breite, M.D.
Volume 22, Number 4, pages 6-9

Diabetic Retinopathy

Jeanne L. Rosenthal, M.D., M.P.O.D., F.A.C.S.
Volume 29, Number 2, pages 18-22

Diagnosing the ‘Disease’ of Central Obesity

Tamara Shan and Samir Desai, M.D.
Volume 32, Number 4, pages 23–27

Diagnosis and Treatment of Diabetic Cardiomyopathy

Harvey L. Katzeff, M.D.
Volume 24, Number 3, pages 6-10

Dietary Protein and Its Influence on Diabetic Nephropathy

Madelyn L. Wheeler, M.S., R.D., C.D., F.A.D.A., C.D.E.
Volume 25, Number 4, pages 16-22

Differential Diagnosis of Reactive Hypoglycemia

Christian D. Herter, M.D., C.D.E.
Volume 21, Number 4, pages 22-29

Direct Renin Inhibition

Curtis Triplitt, Pharm.D., C.D.E., and Shay L. Reichert, Pharm.D., B.C.P.S., C.D.E.
Volume 28, Number 1, pages 6-15

Do Antidiabetic Drugs Using the Incretin Pathway Cause Pancreatitis?

Leann Olansky, M.D.
Volume 30, Number 4, pages 22-25

Eating Disorders and Type 1 Diabetes


Volume 33, Number 1, pages 18-23

Effects of Yoga Therapy on Adhesive Capsulitis in Type 1 Diabetes

John T. Devlin, M.D., Donald Endrizzi, M.D., and Elaine McGillicuddy
Volume 25, Number 3, pages 29-33

Erectile dysfunction


Volume 33, Number 2, pages 22-23

Evidence-Based Treatment of Diabetic Nephropathy

Namyi Yu, M.D., Claudio P. Milite, M.D., and Silvio Inzucchi, M.D.
Volume 24, Number 4, pages 36-41

Fat and Tired

Daniel L. Lorber, M.D.
Volume 24, Number 1, pages 46-47

Fatty Liver Disease as a Cardiovascular Disease Risk Equivalent

Ahmed T. Mohameed, M.D., Howard P. Monsour, M.D., And Kathleen L. Wyne, M.D., Ph.D.
Volume 33, Number 2, pages 12-17

Gastric Electrical Stimulation

John De Csepel, M.D., Brian Goldfarb, M.D., and Corinne Jordan, M.D.
Volume 22, Number 4, pages 14-18

Glucose-Lowering Studies—Time to Move On

Charles A. Reasner, M.D.
Volume 27, Number 2, pages 35-36

How to Recognize and Manage Periodontal Disease in the Diabetic Patient

David J. Lasho, D.D.S., M.S.D.
Volume 27, Number 3, pages 14-16

Hyperinsulinemic Hypoglycemia Following Roux-en-Y Gastric Bypass Surgery

Irene Folaron, M.D., Capt., U.S.A.F., M.C., and Tom Sauerwein, M.D., Lt. Col., U.S.A.F., M.C.
Volume 27, Number 1, pages 10-18

Hypertension and Type 2 Diabetes

Rene Oliveros, M.D., F.A.C.C., Mike Lujan, B.S., and Robert Chilton, D.O., F.A.C.C.
Volume 29, Number 2, pages 11-14

Identification and Management of Charcot Neuroarthropathy

Georgeanne Botek, D.P.M, F.A.C.F.A.S., and Martha Anderson, D.P.M.
Volume 30, Number 1, pages 6-10

Impaired Glucose Tolerance in Polycystic Ovary Syndrome

Andrea Torres, M.D., and John E. Nestler, M.D.
Volume 29, Number 2, pages 15-17

Increased Anemia and Cardiac Problems in Chronic Kidney Disease

William McClellan, M.D., M.P.H., and Daniel Lorber, M.D., C.D.E.
Volume 26, Number 1, pages 21-25

Insulin Resistance and Vascular Dysfunction

Eugenio Cersosimo, M.D.
Volume 27, Number 2, pages 12-16

Interventional Cardiology and the Patient With Type 2 Diabetes

Melanie Sulistio, M.D., Ramavathi Nandyala, M.D., Michael Lujan, B.S., Adrienne S. Zion, Ph.D., and Robert Chilton, D.O., F.A.C.C.
Volume 26, Number 3, pages 6-13

Is Atherosclerosis Different in Patients With Type 2 Diabetes?

Burton E. Sobel, M.D.
Volume 20, Number 2, pages 7-14

Lipid Changes Associated with Diabetes Therapy

John B. Buse, M.D., Ph.D., C.D.E.
Volume 22, Number 1, pages 24-29

Lung Function and Diabetes

Jack M. Mann, M.D., F.A.C.P., F.C.C.P.
Volume 25, Number 2, pages 35-37

Managing Diabetic Dyslipidemia

Peter P. Toth, M.D., Ph.D., F.A.A.F.P., F.N.L.A., F.C.C.P., F.A.H.A., F.A.C.C.
Volume 29, Number 1, pages 18-25

Managing Diet and Obesity in Type 2 Diabetes

Amy Campbell, M.S., R.D., L.D.N. C.D.E.
Volume 26, Number 2, pages 6-10

Managing Major Cardiovascular Risk Factors in Patients with Diabetes

Stephen N. Davis, M.D., F.R.C.P., James R. Sowers, M.D., Douglas E. Vaughan, M.D., F.A.C.C., and Donald S. Nelinson, Ph.D.
Volume 23, Number 3, pages 28-35

Managing Mental Illness in Patients with Diabetes

Jeff Unger, M.D.
Volume 25, Number 2, pages 44-53

Meal Size, Not Body Size, Explains Food Intake Estimation Errors

Brian Wansink, Ph.D., and Pierre Chandon, Ph.D.
Volume 27, Number 4, pages 6-8

Metformin-Suppressible Primary Hyperaldosteronism

Alan Sacerdote, M.D., F.A.C.P., Mark L'Epplatanier, R.P.A., Alireza Toossi, M.D., Gul Bahtiyar, M.D., and Emad Girgis, M.D.
Volume 25, Number 4, pages 37-39

Mitigating Cardiovascular Risks in Diabetes

Arnaud Bastien, M.D.
Volume 26, Number 4, pages 14-17

Modifying Insulin Resistance to Prevent Stroke

Karla Martinez, M.D., Silvio E. Inzucchi, M.D., Catherine Viscoli, Ph.D., and Walter N. Kernan, M.D.
Volume 26, Number 2, pages 19-23

Nonalcoholic Fatty Liver Disease

Neil M. Brodsky, M.D.
Volume 24, Number 4, pages 27-33

Nonalcoholic Fatty Liver Disease: An Overlooked Complication of Type 2 Diabetes

Kenneth Cusi, M.D.
Volume 27, Number 2, pages 18-24

Obesity and Weight Management in Patients with Diabetes

Erin Marie McCarthy, M.S., R.D., L.D.N., Kirsten Webb, N.P., C.D.E., and Robert Kushner, M.D.
Volume 31, Number 1, pages 7–12

Obesity, Insulin Resistance, and Cardiovascular Disease

Tracy McLaughlin, M.D., M.S.
Volume 23, Number 3, pages 6-11

Pathophysiology and Complications of Type 2 Diabetes

Derek D. Mafong, M.D., and Robert R. Henry, M.D.
Volume 28, Number 4, pages 13-26

Podiatric Diabetology

Joseph Alencherry, D.P.M., A.A.C.F.A.S., and Fred DeLucia, D.P.M., A.A.C.F.A.S.
Volume 32, Number 4, pages 28–30

Position Statement: Standards of Medical Care for People With Diabetes Mellitus – Part 2

American Diabetes Association
Volume 22, Number 3, pages 7-27

Position Statement: Treatment of Hypertension in Adults with Diabetes

American Diabetes Association
Volume 22, Number 1, pages 14-19

Practical Prevention and Management of Cardiovascular Disease

Cynthia Rodriguez, M.S. A.R.N.P., F.N.P.-B.C., C.L.S.
Volume 29, Number 1, pages 4-12

Preventing Coronary Artery Disease in Type 2 Diabetes

R. Todd Hurst, M.D., and Richard W. Lee, M.D.
Volume 24, Number 1, pages 14-18

Prevention of Cardiovascular Events in Diabetes

Robert J. Chilton, D.O.
Volume 32, Number 1, pages 6–9

Prevention of Pneumococcal and Other Diseases Through Vaccination


Volume 33, Number 2, pages 18-19

Rational Therapy of Dyslipidemia in Patients With Type 2 Diabetes

Charles A. Reasner, M.D.
Volume 26, Number 4, pages 28-33

Risk Factors for Cardiovascular Disease in Children with Diabetes

Jennifer Miller, M.D., and Janet Silverstein, M.D.
Volume 23, Number 2, pages 13-18

Screening for Asymptomatic Coronary Artery Disease in Diabetes

Samuel Engel, M.D.
Volume 24, Number 3, pages 12-17

Should Glucose Control Prevent Cardiovascular Disease in Type 2 Diabetes?

Kathleen Wyne, M.D., Ph.D.
Volume 33, Number 1, pages 15-17

Should We Use Statins to Lower C-reactive Protein?—Lessons From JUPITER and AURORA

Charles A. Reasner, M.D.
Volume 28, Number 2, pages 24-25

Sleep Apnea

Virginia Zamudio Lange, R.N., M.S.N., C.D.E.
Volume 28, Number 1, pages 16-20

Sleeping Away Diabetic Complications

Michael T. Ledet, M.D.
Volume 29, Number 3, pages 6-9

Standards of Medical Care—2006 (Part 3)

American Diabetes Association
Volume 25, Number 3, pages 8-22

Standards of Medical Care—2006 (Part 4)

American Diabetes Association
Volume 25, Number 4, pages 24-29

Syndromes of Extreme Insulin Resistance

Brian T. Allenbrand, M.D., Capt, USAF, MC, Mark K. Wallace, M.D., Maj, USA, MC, and Tom Sauerwein, M.D., LtCol, USAF, MC
Volume 27, Number 3, pages 17-25

The ACCORD Trial

ACCORD Study Group
Volume 23, Number 4, pages 6-11

The Apples Among Us

Daniel L. Lorber, M.D.
Volume 21, Number 2, pages 23-24

The Bypass Angioplasty Revascularization Investigation in Patients with Type 2 Diabetes (BARI 2D)

Robert L. Frye, M.D., and Saul Genuth, M.D., on behalf of the BARI 2D Investigators
Volume 22, Number 4, pages 24-26

The Diagnosis and Treatment of Diabetic Neuropathy for the Non-Neurologist

Alexandra Hovaguimian, M.D.
Volume 31, Number 2, pages 8–12

The Importance of Ketone Testing

Jonathan Burdick, B.S., Sherrie Harris, B.S.N., M.A., C.D.E., and H. Peter Chase, M.D.
Volume 23, Number 2, pages 19-26

The Polycystic Ovary Syndrome and Insulin Resistance

Nausheen Akhter, B.A., and John E. Nestler, M.D.
Volume 20, Number 3, pages 16-23

The Pre-Charcot Foot

Peter Levine, D.P.M., Julia Kaplun, M.D., Dennis Shavelson, D.P.M., and Leonid Poretsky, M.D.
Volume 25, Number 3, pages 24-28

The Role of Aspirin in the Prevention of Cardiovascular Events in Diabetes

Shailesh Nandish, M.D., and Robert Chilton, D.O., F.A.C.C.
Volume 30, Number 1, pages 11-13

Tight Glycemic Control and Cardiovascular Events

Charles A. Reasner, M.D.
Volume 27, Number 3, pages 26-27

Treatment of Diabetic Gastroparesis

Alan Sacerdote, M.D., F.A.C.P., Isaac Wasserman, M.D., and Gilbert Enenajor, M.D.
Volume 22, Number 4, pages 10-13

Treatment of Erectile Dysfunction in Diabetic Men

Ann Ezzell, B.A., and Neil Baum, M.D.
Volume 26, Number 4, pages 18-21

Treatment of Low HDL Cholesterol Level—Too Little, Too Late

Charles A. Reasner, M.D.
Volume 28, Number 1, pages 29-31

Understanding the Links Between Insulin Resistance, Diabetes, and Cardiovascular Risk

Melvin R. Hayden, M.D., and Brian S. McGowan, Ph.D.
Volume 24, Number 2, pages 6-14

Use of Bile Acid Sequestrants to Treat Type 2 Diabetes

Charles A. Reasner, M.D.
Volume 28, Number 2, pages 6-15

Using Sulfonylureas in Patients with Renal Insufficiency

Kendall M. Campbell, M.D., and James R. Taylor, Pharm.D., C.D.E.
Volume 27, Number 4, pages 21-24

Vitamin D Deficiency and Diabetes

David S.H. Bell, M.B., F.A.C.E.
Volume 30, Number 4, pages 6-21

Weight Management and Diabetes

Kathleen Wyne, M.D., Ph.D.
Volume 32, Number 3, pages 30–32

What is the Role of Glucose Control in the Prevention of Cardiovascular Disease in Type 2 Diabetes?


Volume 34, Number 2, pages 12-13

Why Is There More Cardiovascular Disease in Diabetes?

Daniel L. Lorber, M.D.
Volume 25, Number 4, pages 10-15